156 related articles for article (PubMed ID: 29435721)
1. Selection and identification of novel peptides specifically targeting human cervical cancer.
Liu X; Peng J; He J; Li Q; Zhou J; Liang X; Tang S
Amino Acids; 2018 May; 50(5):577-592. PubMed ID: 29435721
[TBL] [Abstract][Full Text] [Related]
2. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
[TBL] [Abstract][Full Text] [Related]
3. Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library.
Li C; Gao N; Xue Q; Ma N; Hu Y; Zhang J; Chen B; Hou Y
Biotechnol Lett; 2017 Oct; 39(10):1463-1469. PubMed ID: 28634746
[TBL] [Abstract][Full Text] [Related]
4. Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.
Lee KJ; Lee JH; Chung HK; Choi J; Park J; Park SS; Ju EJ; Park J; Shin SH; Park HJ; Ko EJ; Suh N; Kim I; Hwang JJ; Song SY; Jeong SY; Choi EK
Amino Acids; 2015 Feb; 47(2):281-9. PubMed ID: 25366491
[TBL] [Abstract][Full Text] [Related]
5. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary screening and identification of a peptide that binds specifically to gastric cancers cells with high metastasis to peritoneum].
Bai FH; Wang J; Zhao PT; Cao SS; Lei T; Li Y; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):659-63. PubMed ID: 16681920
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
8. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
Yang X; Zhang F; Luo J; Pang J; Yan S; Luo F; Liu J; Wang W; Cui Y; Su X
Oncol Rep; 2016 Jul; 36(1):79-89. PubMed ID: 27221614
[TBL] [Abstract][Full Text] [Related]
9. A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells.
Li G; Yin Q; Ji H; Wang Y; Liu H; Jiang L; Zhu F; Li B
Drug Des Devel Ther; 2018; 12():3899-3912. PubMed ID: 30519000
[TBL] [Abstract][Full Text] [Related]
10. OSTP as a novel peptide specifically targeting human ovarian cancer.
Yang C; He X; Liu X; Tang Z; Liang X
Oncol Rep; 2015 Aug; 34(2):972-8. PubMed ID: 26081347
[TBL] [Abstract][Full Text] [Related]
11. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel drug targeting delivery system for cervical cancer therapy.
Xiao L; Ma N; He H; Li J; Cheng S; Yang Q; Hou Y; Song F; Jin H; Su X; Dong J; Zuo R; Song X; Duan W; Hou Y
Nanotechnology; 2019 Feb; 30(7):075604. PubMed ID: 30523991
[TBL] [Abstract][Full Text] [Related]
13. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
[TBL] [Abstract][Full Text] [Related]
14. Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma.
Lee KJ; Lee JH; Chung HK; Ju EJ; Song SY; Jeong SY; Choi EK
Amino Acids; 2016 Apr; 48(4):1079-1086. PubMed ID: 26759016
[TBL] [Abstract][Full Text] [Related]
15. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
[TBL] [Abstract][Full Text] [Related]
16. [Screening and identification of peptides specifically binding to human osteosarcoma cells].
Lu K; Jiang Y; Guan M; Xiao J; Wang J; Li Z; Shi Z
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):647-50. PubMed ID: 22588916
[TBL] [Abstract][Full Text] [Related]
17. Phage display-derived peptides for osteosarcoma imaging.
Sun X; Niu G; Yan Y; Yang M; Chen K; Ma Y; Chan N; Shen B; Chen X
Clin Cancer Res; 2010 Aug; 16(16):4268-77. PubMed ID: 20570932
[TBL] [Abstract][Full Text] [Related]
18. CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
Lee S; Ho JY; Liu JJ; Lee H; Park JY; Baik M; Ko M; Lee SU; Choi YJ; Hur SY
Mol Med; 2019 May; 25(1):23. PubMed ID: 31138113
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
